Nuovi dati

28  Download (0)

Full text

(1)

SESSIONE TUMORI GENITOURINARI:

NUOVI DATI

Dott. Antonio Rozzi

Oncologia INI Grottaferrata

(2)

Overview

Prostate Cancer

• LBA31 STAMPEDE: Abiraterone or Docetaxel –directly randomised data

Renal Cell Carcinoma

• LBA5 CheckMate214: Phase III Nivolumab+

Ipilimumab vs Sunitinibfor clear cell mRCC

Bladder Cancer

• LBA4 RANGE: Phase III Docetaxel +/-

Ramucirumab in platinum-refractory urothelial cancer

(3)

Newly Diagnosed CS Metastatic Prostate Cancer

(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)

LBA31 STAMPEDE: Abi or Doc – directly randomised data -No difference in OSS, SSE for ADT+Abi vs ADT+Doc

- Different mechanism of action , side effect profile, treatment duration (18 wks Doc vc until PD for Abi), cost-

effectiveness ratio, …

(12)

Renal Cell Carcinoma

(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)

GRAZIE !!!

Figure

Updating...

References

Related subjects :